Stocktoria
Revolution Medicines, Inc. RVMD
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-02-13
Revolution Medicines, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 13,408,713 | $520.4M |
| TWO SIGMA INVESTMENTS, LP | 1,558,807 | $151.6M |
| D. E. Shaw & Co., Inc. | 2,658,843 | $107.6M |
| CITADEL ADVISORS LLC | 1,004,453 | $97.7M |
| MILLENNIUM MANAGEMENT LLC | 464,160 | $36.9M |
| AQR CAPITAL MANAGEMENT LLC | 116,787 | $11.4M |
| RENAISSANCE TECHNOLOGIES LLC | 6,200 | $602,950 |
| Point72 Asset Management, L.P. | 2,600 | $252,850 |
Source: SEC EDGAR filings · CIK 0001628171 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.